T85.820

Clinical Causes: Introduction of foreign materials during the implantation or grafting procedures within the nervous system. Chronic inflammatory responses triggered by the body's immune system reacting to the prosthetic device or graft. Mechanical irritation or trauma related to the placement or movement of the device or graft. Infection at the site of implantation or graft that promotes fibrosis as part of the healing process. Individual patient factors such as predisposition to excessive scarring or fibrosis. Material composition and biocompatibility of the prosthetic device or graft used.

Key Symptoms: Localized swelling or palpable firmness around the implant site. Pain or discomfort, which may range from mild to severe. Sensory disturbances, including numbness or tingling in areas supplied by affected nerves. Reduced mobility or function in the region involved due to nerve compression or irritation. Signs of inflammation such as redness, warmth, or increased tenderness around the site. Possible neurological deficits depending on the location and extent of fibrosis.

Diagnosis Path: Physical examination to assess swelling, tenderness, and neurological function. Imaging studies such as magnetic resonance imaging (MRI) or ultrasound to visualize fibrotic tissue and surrounding structures. Electrophysiological tests, including nerve conduction studies or electromyography (EMG), to evaluate nerve function. Histopathological examination of tissue biopsy samples, if necessary, to confirm fibrosis and exclude other causes. Review of patient history, including type of implant or graft, duration since placement, and any prior complications.

Treatment Protocols: Medical therapies such as anti-inflammatory medications or corticosteroids to reduce inflammation and fibrosis progression. Physical therapy to maintain or improve mobility and prevent contractures resulting from scar tissue. Minimally invasive procedures like image-guided needle aspiration or corticosteroid injections targeted at fibrotic tissue. Surgical intervention may be considered to remove or modify scar tissue if symptoms are severe or worsening. Adjustments or replacements of the existing device or graft in cases where it contributes significantly to fibrosis. Monitoring and follow-up assessments to evaluate response to treatment and detect additional fibrotic changes.